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Abstract 
Enterotoxigenic  Escherichia  coli (ETEC)
infection is the most common type of porcine
postweaning colibacillosis (PWC). Among fim-
briae of porcine ETEC strains the best studied
family  of  fimbriae  are  the  members  of  F4
adhesins, existing in at least three variants:
ab,  ac,  ad.  Active  immunization  against
porcine PWC is difficult due to: i) ETEC strains
are only one of the essential predisposing fac-
tors, ii) the success of vaccinal antigen uptake
depends on the presence of enterocyte recep-
tors  for  F4  adhesins,  iii)  the  intestinal
immune system may react with tolerance or
hypersensitivity to the same antigens depend-
ing  on  the  dose  and  form  of  the  vaccinal
immunogen, and iv) kinetics of the specific
immune  responses  may  be  different  in  the
case  of  F4  (earlier)  and  the  other  ETEC
adhesins, particularly F18 (later). The aim of
this study was to test the effectiveness of a live
attenuated  F4ac+ non-ETEC  vaccine  against
porcine PWC by analyzing quantitative differ-
ences  in  the  small  intestinal  lymphoid  and
myeloid cell  subsets of immunized (with or
without levamisole given as an adjuvant) vs
control  non-immunized  pigs.  Four  week-old
pigs were intragastrically immunized with a
vaccine candidate F4ac+ non-ETEC strain 2407
at day 0, challenged 7 days later with a virulent
F4ac+ strain ETEC 11-800/1/94, euthanatized at
day 13 and sampled for immunohistology. Non-
immunized pigs received saline at day 0 and
were  processed  as  the  principals.  Immuno-
phenotypes of lymphoid and myeloid cell sub-
sets  were  demonstrated  within  jejunal  and
ileal mucosa by immunohistochemical avidin-
biotin  complex  method  and  corresponding
morphometric data were analyzed using soft-
ware program Lucia G for digital image analy-
ses. Monoclonal antibodies reactive with sur-
face molecules on porcine immune cells such
as CD3, CD45RA, CD45RC, CD21 and SWC3
enabled clear insight into distribution patterns
and amount of these cells within the gut-asso-
ciated lymphoid tissues (GALT) examined. The
numbers of jejunal and ileal cell subsets tested
were  significantly  increased  (at  P<0.5  or
lower) in both principal groups (vaccinated or
levamisole  primed-vaccinated)  of  pigs,  com-
pared to those recorded in the control non-vac-
cinated pigs. Based on the histomorphometric
quantification  of  porcine  intestinal  immune
cells from the GALT compartments tested, it is
possible to differentiate the responses of pigs
immunized by an experimental mucosal vac-
cine from those of non-immunized pigs.
Introduction
Intestinal  mucosal  surfaces  represent  the
entry route of a wide range of harmless dietary
antigens  and  harmful  viral  and  bacterial
pathogens.  Certain  enteric  pathogens  take
advantage of host or other factors (such as diet
or  stress),  which  may  alter  or  weaken  gut
immune system defences. For many of these,
such  as  porcine  enterotoxigenic  Escherichia
coli (ETEC) strains etiological agents of post-
weaning colibacillosis (PWC), no effective vac-
cine  exists.  Hence,  it  is  important  that
prospective  vaccines  engender  maximal
immunity at these susceptible sites. Promising
candidates that might be able to manage suffi-
cient  protection  include  live  attenuated  oral
vaccine with F4ac+ non-ETEC strain. Porcine
PWC is economically one of the most signifi-
cant disease of swine, which encountered for
the  major  productive  losses  in  the  swine
industry due to morbidity, mortality or retarded
growth. Commonoly induced by ETEC strains
that mostly carry F4 or F18 fimbriae, it is etio-
logically complex disease triggered by numer-
ous stressful events (i.e. weaning) and recent-
ly,  an  increase  in  incidence  of  outbreaks  of
severe  E.  coli-associated  diarrhea  has  been
observed  worldwide.1 Lallès  et  al.2 discussed
the influence of weaning and nutrition in the
postweaning  period  on  intestinal  physiology
and mucosal immunology. The ETEC strains
isolated from pigs with PWC produce entero-
toxins that may induce a severe watery diar-
rhea, starting 3-10 days after weaning. It is
widely accepted that specific serotypes/patho-
types of ETEC are responsible for the major
part of PWC, but only a part although an essen-
tial one.3 It is also without dabate that weaning
is  a  period  during  which  there  is  a  great
change in the magnitude and variety of expo-
sure to environmental antigens derived from
food and potentially pathogenic microbes. As a
consequence PWC commonoly occurs in pigs
weaned abruptly at 3-5 weeks, and it is quite
clearly associated with the event of weaning,2
accompanied with various other predisposing
factors such as environmental, nutritional and
physiological  changes.  Because  parenterally
administrated vaccines tend to stimulate sys-
temic rather than local (intestinal) immune
responses,4 novel  strategies  are  aimed  at
designing of mucosal vaccines with attenuated
non-ETEC strains producing F4 or F18 fimbrial
antigens.1
The  extensive  research  of  Dacko  et  al.5
made possible classification of E. coli strains
isolated  from  diarrheic  suckling  piglets  into
several groups: ETEC, vero- or Shigatoxigenic
(VTEC  or  STEC),  enteroaggregative  (EAEC),
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enteropathogenic (EPEC) and necrotoxigenic
(NTEC).  The  study  demonstrated  that  the
majority of the isolates (59.6%) were able to
produce  heat-labile  (LTI)  and/or  heat-stable
(STI) enterotoxins, and these were classified
as typically ETEC strains. Zhang et al.6 have
found the prevalence of F4 fimbrial genes in E.
coli strains isolated from young pigs with PWC
in the USA. Moreover, all toxin genes except
the EAST1 toxin gene, were almost exclusively
associated with F4+ or F18+ isolates, and most
of these isolates carried multiple toxin genes.
The present study is aimed at evaluation of
the immunogenicity of attenuated F4ac+ non-
ETEC vaccine candidate strain against porcine
PWC. We have tested the effectiveness of live
oral vaccine by analyzing quantitative differ-
ences  in  lymphoid  and  myeloid  cell  subsets
within  the  gut-associated  lymphoid  tissues
(GALT) of weaned pigs specifically immunized
(with or without levamisole applied as an adju-
vant)  vs control  non-immunized  and  chal-
lenged pigs with homologous ETEC strain.
Materials and Methods
Bacterial strains
The recombinant avirulent F4ac+ non-ETEC
vaccine  candidate  strain  2407  (serotype  O9:
K36: H19: F4ac: LT
– STb
–) kindly donated by dr.
sc.  Thomas  A.  Casey  from  NADC,  Ames,  IA,
USA,  was  used  for  the  immunization.7 The
authentic  F4ac+ ETEC  strain  11-800/1/94
(serotype  O149:  K91:  F4ac:  987P:  Hly+ LT+
STb+),  isolated  from  diarrheic  pigs  aging
between 3 and 4 weeks reared on swine farms
in Croatia, was used for the challenge infec-
tion.  Both  strains  were  kept  in  the  glycerin
broth at -80°C until used.
Monoclonal antibodies
The mAbs reactive with porcine leukocyte
surface molecules i.e. cluster of differentiation
(CD) antigens that we have used to study in
situ identification, distribution and quantifica-
tion  patterns  of  respective  lymphoid  and
myeloid cell subsets are listed in Table 1.
Study design
Fifteen conventionally reared crossbred pigs
(Swedish Landrace x Yorkshire) from a large
scale swine farm nearby Zagreb, Croatia were
weaned at 4 weeks of age and purchased for
this experiment. The pigs were housed in the
animal  facility  at  the  Veterinary  Faculty
University of Zagreb and fed with a standard
weaner diet. They were randomly divided into
three groups comprising 5 animals each. After
two days of accommodation pigs were treated
as  follows:  control  non-immunized  pigs
received 5 mL of saline intramuscularly (i.m.)
at day 0, principal pigs were intragastrically
(i.g.) immunized with 1010 CFU/mL of F4ac+
non-ETEC vaccine candidate strain 2407 in 60
mL of TSB at day 0 or i.m. primed with lev-
amisole (Nilverm®; Pliva, Zagreb, Croatia) at
the immunostimulatory dose of 2.5 mg/kg over
three  consecutive  days  (-2,  -1,  0)  and  i.g.
immunized  with  10
10 CFU/mL  of  F4ac
+ non-
ETEC vaccine candidate strain 2407 in 60 mL
of TSB at day 0. Seven days later all pigs were
challenged  with  10
10 CFU/mL  of  F4ac+ ETEC
strain 11-800/1/94, and three out of each group
were euthanatized at day 13 and sampled for
immunohistology.
All  treatments  of  pigs  were  conducted  in
accordance  with  the  "Directive  for  the
Protection  of  Vertebrate  Animals  used  for
Experimental  and  other  Purposes"
(86/609/EEC).
Clinical observations
Clinical observations for signs of colibacillo-
sis, such as diarrhea, dehydration, weight loss,
weakness and anorexia were recorded three
times  daily  by  the  person  blinded  to  given
treatments. Pigs were weighed at the begin-
ning of the trial (day -2), and 7 and 10 days
after the immunization (at day 0) or 4 days
after  the  challenge  infection.  The  diarrhea
developed  by  pigs  was  graded  on  a  scale  of
intensity where scores (per pig per day of the
experiment) were given based on stools con-
sistency:  +,  soft  feces  =  mild  diarrhea;  ++,
fluid feces = moderate diarrhea; +++, watery
feces = severe diarrhea. Pigs with normal firm
feces were scored as diarrhea negative (-).
Isolation of vaccine and challenge
strains from the feces
Beginning with day -2 before the treatments
with levamisole, rectal swabs were taken from
each pig and also at days 7 and 13 following
immunization  and  challenge  infection.
Samples were diluted in serial dilutions up to
1010 in saline and 1 mL of each dilution was
placed  onto  TSB  with  5%  sheep  blood  agar
(Blood Agar Base, No.2, OXOID CM 271). After
incubation at 37°C overnight, the numbers of
colony-forming  units  (CFU)  per  mL  were
determined by counting on an automatic com-
puter-assisted  counter.  Five  E.  coli colonies
from  each  plate  were  serotyped  by  a  slide
agglutination  test  using  rabbit  OK  antisera
prepared  from  standard  E.  coli  strains
(Croatian  Veterinary  Institute,  Zagreb,
Croatia). Hemolytic isolates identified by plat-
ing on 5% sheep blood agar with esculine were
further  serologically  checked  for  F4  fimbrial
antigens. The presence or absence of heat sta-
ble  and  heat  labile  enterotoxins  were  con-
firmed  using  commercial  test  kits  as  afore
mentioned. To detect natural infections with
other E. coli strains, faecal samples were also
plated onto plain agar.  
Tissue sampling and immunohisto-
chemical staining
Samples  of  middle  part  of  jejunum  and
ileum  were  collected  immediately  after
euthanasia and fixed (as 10x10x5 mm blocks)
in  fresh  10%  neutral  buffered  formaldehyde
(pH 7.0-7.6) for 24 hours. Tissue blocks were
then  dehydrated  in  75%,  80%,  95%,  100%
ethanol and embedded in paraplast embedding
media (Sigma, Deisenhofen, Germany).
Paraplast-embedded sections were cut at 5
µm and floated on a water bath containing dis-
tilled water, heated at approximately 42°C. The
selected sections are picked up with the pre-
coated slides and dried horizontally on a 37°C
warming tray overnight. Then, the slides were
dewaxed in xylene three times for 5 minutes
each, hydrated in 100%, 95%, 80%, 75% ethanol
for 3 minutes, washed in phosphate buffered
saline (PBS) pH 7.2 twice for 3 minutes each
and immersed into distilled water for 5 min-
utes.
Immunohistochemical  staining  was  per-
formed  by  the  avidin  biotin  complex  (ABC)
method.8,9 For blocking of endogenous peroxi-
dase activity, the slides were immersed into
3% hydrogen peroxide solution for 30 minutes,
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Table 1. The mAbs specific for swine leukocyte CD/SWC antigens used in immunohisto-
logical demonstration of porcine intestinal lymphoid and myeloid cell subsets.
Marker antigens mAbs Cells Donor*
CD3a BB23-8E6 T cells Pescovitz
CD3b FY1H2 T cells Yang
CD45RA MIL13 Naïve T cells Haverson
CD45RC MIL5 Memory T cells Stokes
CD21 BB6-11c9 B cells Pescovitz
SWC3 74-22-15 Macrophages, monocytes, granulocytes Lunney
*Kindly donated for research purposes and testings for the Swine CD Workshops held in Davis, CA, USA (1995), Ludhiana, India
(1998), and Amsterdam, Netherlands (1999).[page 20] [European Journal of Histochemistry 2010; 54:e4]
then washed in PBS for 2x3 minutes, drained
and  wiped.  Blocking  of  background  staining
was performed by incubating the intestinal tis-
sue sections with 5% rabbit serum and 5% pig
serum diluted in PBS, for 30 minutes at room
temperature in a humid chamber. The blocking
serum  was  tapped  off  and  the  excess  was
wiped away without rinse. The primary anti-
body (mouse anti-swine), diluted 1:2 in PBS
with  1%  swine  serum  and  1%  rabbit  serum
were added to cover the sections and incubat-
ed for 1 hour at room temperature. Also, nega-
tive control sections either without primary or
secondary antibody were prepared. Slides were
gently rinsed in PBS bath for 3x5 minutes and
wiped.  The  secondary  antibody  (biotinylated
rabbit  anti-mouse  IgG)  (Sigma,  St.  Louis,
USA) diluted 1:500 in PBS was applied to cover
the tissue sections and incubated at room tem-
perature for 1 hour. Slides were rinsed three
times for 5 minutes each in PBS, wiped and
the tertiary antibody (streptavidin- peroxidase
complex)  (ICN,  ImmunoBiologicals,  USA)
diluted 1:1000 in PBS was applied for 1 hour at
room temperature. After rinsing three times
for 5 minutes each in PBS, the reaction was
visualized  with  a  0.05%  solution  of  3,3-
diaminobenzidine tetrachloride (DAB) in 0.05
M Tris-HCl (pH 7.6) containing 0.01% H2O2.
The sections were dehydrated in raising con-
centrations of ethanol, mounted in canada bal-
sam and coverslip.
Morphometric analyses 
Immunophenotypes  of  lymphoid  and
myeloid cell subsets within jejunal and ileal
mucosa demonstrated by immunohistochemi-
cal ABC method were analyzed using software
program  Lucia  G  for  digital  image  analyses
(DIA). Morphometric analyses were performed
by counting of the immune cells in 12 random-
ly  selected  tissue  section  fields  at  x200  on
screen  magnification  including  the  areas  of
lamina propria and adjacent epithelium, the
areas of villus and crypts and also the Peyer’s
patches.  The  results  are  expressed  as  the
mean  values  and  standard  deviations  of  the
number of jejunal and ileal immune cells per
mm2 of  an  average  tissue  section  field  of
672387.5  mm2.  Mean  values  of  stained  cell
numbers for each group were compared using
statistical analysis.
Statistical analysis
Data  were  analyzed  by  a  non-parametric
Mann-Whitney U test and differences between
number of cells recorded in principal and con-
trol groups were considered as significant at
P<0.05 and lower values.
Results
Clinical examinations
The mean weight (kg ±SD) per group of pigs
at day -2 were as follows: control = 7.43±1.44
vaccinated = 6.25±0.7 and levamisole-primed
vaccinated = 6.68±0.8. All these body weights
were statistically similar. Seven days following
the  treatments,  vaccinated  pigs  had  much
lower (P<0.05) body weight (4.75±0.6) as com-
pared to that in control pigs (7.75±1.0). Weight
gain in levamisole-primed vaccinated pigs was
also lower (5.93±0.5), but not significantly. Ten
days after the treatments, vaccinated pigs still
gain weight slower (5.5±1.0) although not sig-
nificantly. In the control pigs (8.68±1.3) as well
as  in  levamisole-primed  vaccinated  pigs
(7.75±0.5) body weight was increased 10 days
after the treatments. However, such increases
were not significantly different between days 2
and 10. All pigs gained body weight 4 days fol-
lowing  challenge  inoculation,  but  the  values
were not significantly different between days 2
and 13 of the experiment.
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Table 2. Extent of diarrhea intensity expressed as scores based on stools consistency: -,
firm feces = no diarrhea; +, soft feces = mild diarrhea; ++, fluid feces = moderate diarrhea;
+++, watery feces = severe diarrhea.
Treatment of pigsa Pig no. Day of experiment
12345 6 7 8 9-13
Noneb 1
2 ++ ++ +++ ++ ++
3 ++ ++
4 ++ ++
5
F4ac+non-ETEC 1+ + ++ ++
2 ++ ++ ++ ++
3 ++ +++ +++ ++ ++ ++ ++
4 ++ +++ ++ ++ ++ ++ ++ +++ c
5+ + ++ ++
Levamisole +F4ac+ 1 ++ +++ +
non-ETEC 2+ +
3 ++ ++ +++ ++ ++ ++
4 +++ +++ c
5+ +
aGroups comprised five 4-weeks-old pigs each. bControl pigs received saline as a placebo. cDied at either Day 9 or Day 3 due to diar-
rheal disease.
Table 3. Isolation and quantification of E. coli strains from either rectal swabs or intes-
tinal  contents  of  weaned  pigs  before  and  after  the  treatments;  numerical  data  are
expressed as either average values of CFU/mL or percent values of hemolytic colonies in
the isolates for each group of pigs.
Treatment  Day of  No. of E. coli E. coli CFU/mL Hemolytic
of pigsa experiment positive pigs/ isolate isolates (%)
total no. of pigs
None -2 3/5 O8:K87:F4acc --
7 5/5 E. colid --
10 1/5 E. coli --
13 4/5 O138:K81, 3.0x107 10
O149:K91:F4ac 1.0x106 20
F4ac+ non-ETEC -2 1/5 E. coli --
7 2/5 O8:K87:F4ac : - 75
O9:K36:H19:F4ac
10 4/5 O149:K91:F4ac --
13 2/5 O149:K91:F4ac 5.5x10
6 22.5
Levamisole + F4ac+ -2 1/5 O8:K87:F4ac --
non-ETEC 7 3/5 E. coli --
10 1/5 E. coli --
13 5/5 O8:K87:F4ac 3.5x106
O9:K36:H19:F4ac 2.5x106 15.0
aGroups comprised five 4-weeks-old pigs each. bControl pigs received saline as a placebo. c”Farm strain”.  dNon-pathogenic strain.[European Journal of Histochemistry 2010; 54:e4] [page 21]
Fecal shedding of the vaccine and
challege strain
The isolated E. coli strains and their num-
bers  were  assessed  from  the  rectal  swabs
before and after the treatments as shown in
Table  3.  The  vaccine  candidate  strain
(O9:K36:H19:F4ac) was isolated from none of
controls, 2/5 vaccinated (at Day 7) and 5/5 lev-
amisole  primed-vaccinated  pigs  (2.5x106
CFU/mL) at day 13 of the experiment. Thus,
the vaccine candidate strain (applied in the
concentration of 10
10CFU/mL at day 0) could be
cultured in a minor quantity of 0.25% 14 days
after  the  specific  immunization.  This  strain
could  not  be  recovered  from  neither  fecal
material nor intestinal content in F4ac+ non-
ETEC strain treated pigs. We were able to iso-
late challenge strain (O149:K91:F4ac) from 4/5
and 5/5 control and vaccinated pigs (1.0x106
and 5.5x106  CFU/mL), respectively, at day 13 of
the experiment. However, the challenge strain
cold not be recovered from levamisole primed-
vaccinated pigs. We speculate that this occurs
due to the prolonged presence (from day -2 to
day  13)  of  homologous  farm  strain
(O8:K87:F4ac:Hly
–)  in  the  gastrointestinal
tract of these pigs, which resulted in its more
rapid passage through the intestines following
challenge infection. Although in minor quanti-
ties,  we  were  able  to  isolate  both  vaccinal
(0.25%) and challenge strain (0.10-0.55%) 14
or 7 days following the inoculation, respective-
ly. It seems that challenge strain was passing
through  the  intestines  almost  three  times
slower than the vaccinal strain. Accordingly, it
would be more appropriate to vaccinate pigs on
at  least  three  consecutive  days,  starting  at
weaning with much higher doses of vaccine
candidate strain.   
Immunohistochemical findings
The in situ localization and distribution pat-
terns of lymphoid and myeloid cells within jeju-
nal and ileal mucosa are shown in Figure 1 a-
e. According to location numerous CD3+ cells
are among intraepithelial lymphocytes. CD3+ T
cells  were  uniformly  distributed  between
crypts and villi. The cells expressing CD3 anti-
gen were also found in the mucosal lamina
propria  and  inside  the  follicles  of  Peyer's
patches. We have found numerous clusters of
CD3+ T lymphocytes in the interfollicular area.
CD45RA+ naive T cells were more abundant in
the crypts area whereas CD45RC+ memory T
cells were mostly found in the villi and interfol-
licular areas. Predominance of CD45RA+ naïve
T cells was found in Peyer’s patches and these
cells were also numerous in the extrafollicular
areas.  The  CD45RC+ memory  T  cells  were
abundant in the mucosal lamina propria and in
the  interfollicular  areas,  but  quite  scarce  in
Peyer’ patches. Numerous CD21+ B cells were
observed in the villi: these cells were also fre-
quent  in  the  mucosal  lamina  propria  and
inside the follicles of Peyer's patches. SWC3
+
myeloid  cells  (marcophages/granulocytes)
were particularly frequent in the areas directly
below the epithelium of the villi, in the mucos-
al  lamina  propria  and  between  the  crypts.
Small  amount  of  these  cells  was  scattered
through ileal Peyer's patches. 
Histomorphometric findings
Following  oral  administration  of  vaccine
candidate  F4ac+ non-ETEC  strain  (with  or
withou levamisole applied as an adjuvant) and
challenge infection with the homologous ETEC
strain,  we  have  evaluated  the  intestinal
immune  responses  of  immunized  pigs  by
quantification  of  numbers  of  their  CD3+,
CD45RA+, CD45RC+ and CD21+ lymphoid and
SWC3+ myeloid cells in the sections of jejunum
(Table 4) and ileum (Table 5) using a comput-
er-assisted histomorphometry. 
Quantitative  immunophenotypic  analyses
showed that pigs immunzied with F4ac+ non-
ETEC    vaccine  candidate  strain  had  highly
increased numbers of jejunal and ileal CD3+ T
cells  (P<0.001  and  P<0.05,  respectively)  as
compared  to  those  recorded  in  non-treated
control pigs (Table 4 and Table 5). In the pigs
immunized  with  levamisole  adjuvanted  vac-
cine these cells were also highly elevated in
the  mucosal  sites  of  jejunum  (P<0.01)  and
ileum (P<0.001). Naive and memory T cells
(expressing  isoforms  of  CD45RA+ and
CD45RC+surface antigens) were also signifi-
cantly increased in the jejunum (P<0.001 and
P<0.01, respectively) of boths principal groups
of  pigs.  While  CD45RA+ cells  were  also
increased in the ileum of both principal groups
(P<0.001 and P<0.05), CD45RC
+ were higher
than the control values  (P< 0.05) in the ileum
of pigs that had been immunized with nonad-
juvanted  and  levamisole-adjuvanted  vaccine,
but not in the ileum of  pigs immunized with
nonadjuvanted  vaccine. Both principal groups
of pigs had increased numbers of CD21+B cells
within  both  jejunum  (P<0.001  and  P<0.05)
and ileum (P<0.001 and P<0.01). Similar find-
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Figure  1.  Immunohistochemical  localiza-
tion of CD3+ T cells in the interfollicular
area of ileum (a), CD45RA+ naïve T cells
in the lamina propria and between crypts
of jejunum (b), CD45RC+ memory T cells
in ileal lamina propria and Peyer’s patches
(c), CD21+ B cells (d) and SWC3+ myeloid
cells  (e)  in  the  lamina  propria  of  ileum
from 4-week-old pig as demonstrated by
ABC method; original magnification 200x.
b
cd
e
a[page 22] [European Journal of Histochemistry 2010; 54:e4]
ing  was  observed  for  SWC3+ marcophages/
granulocytes (Table 4 and Table 5). The effect
of levamisole when given as an ajuvant with
the  experimental  vaccine  was  calculated  by
comparison to nonadjuvanted vaccine. A sig-
nificant difference was obtained only for the
number of CD21+ B cells (at P<0.5) which was
slightly higher in the pigs treated with vaccine
candidate strain than in the pigs treated with
levamisole plus vaccinal strain (Table 4).
Discussion
As the preventive use of antibiotics in vet-
erinary medicine became prohibited in the EU
there is a rapidly increasing need for alterna-
tive approaches in the area of swine colibacil-
losis as well. Other approaches to control this
disease include, beside attenuated E. coli vac-
cines, supplementation of feed with egg yolk
antibodies from the chickens immunized with
F4 or F18 fimbriae, breeding of F18– and F4-
resistant swine, supplementation of diets with
zinc, medium-chain fatty acids and/or spray-
dried plasma, dietary acidification, phage ther-
apy or the use of probiotics.1,3,11 However, it
shoud be taken into consideration that immu-
nization methods and routes for inducing sys-
temic  immunity  often  delayed  or  prevented
induction  of  mucosal  immunity  and  vice
versa.
12 Namely, parenterally administrated E.
coli vaccines tend to stimulate systemic rather
than the mucosal immune system.4 Alexa et
al.
13 suggested the efficiency of combined par-
enteral and oral immunization against ETEC
diarrhea  in  weaned  piglets.  Felder  et  al.14
examined the feasibility of peroral immuniza-
tion  with  microencapsulated  E.  coli and
detached fimbriae to prevent ETEC infections
in pigs. In 2002, Cox et al.15 have reported that
oral administration of F4 fimbrial antigens to
the F4R+ pigs resulted in an intestinal mucos-
al immune response that completely protected
the pigs against a challenge infection, while in
F4R- pigs such response did not occur. Snoeck
et al.16 studied the feasibility of oral vaccina-
tion of suckling piglets against F4+ ETEC infec-
tion with F4 fimbriae, but despite the induc-
tion of an immune response, the colonization
of the small intestine by F4+ ETEC upon oral
challenge could not be prevented. Application
of F4 or F18 fimbriae in microspheres has also
not proven useful.17 The protective effects of
DNA vaccines (using whole plasmids contain-
ing specific virulence genes of ETEC) are still
far  to  be  seen.18 In  2004,  Verdonck  et  al.19
reported that oral immunization of piglets with
recombinant  F4  fimbrial  adhesin  FaeG
monomers induced both mucosal and systemic
F4-specific  immune  responses.  Such  live
attenuated oral vaccines have been suggested
to be relatively effective in preventing ETEC-
induced  PWC  in  pigs,  but  the  mechanisms
responsible for protection have not been eluci-
dated. Priming by levamisole of the vaccinated
pigs  has  a  tendency  to  trigger  the  mucosal
rather  than  systemic  immune  system  and
abrogates the inefficacy of vaccination against
porcine PWC induced by the vaccine alone.20
Božić et al.21 suggested that enhanced recruit-
ment and activation of T cells in ileal Peyer's
patches was a consequence of an interaction
between resident T and B cells of levamisole
primed vaccinated pigs. Snoeck et al.22 have
shown  that  jejunal  Peyer’s  patches  are  the
major inductive sites for the F4-specific intes-
tinal  antibody  responses.  Božić et  al.23
observed that priming by levamisole of weaned
pigs  vaccinated  with  experimental  F4ac+ E.
coli oral vaccine stimulated their gut immune
system,  including  the  immune  cell  subsets
within jejunal lamina propria and ileal Peyer's
patches, upon virulent challenge. Božić et al.24
implied that levamisole exerts its potentiating
activity in the mesenteric lymph node by aug-
menting  both  recruitment  and  activation  of
cells  that  participate  in  the  cell-mediated
immunity. More recent study,25 suggested that
synergistic  action  of  the  drug  and  vaccine
enhanced  the  T  cell-mediated  immunity  in
ileal Peyer’s patches. The results of our current
study  showed  that  vaccine  candidate  F4ac+
non-ETEC  strain  stimulated  increase  in  the
numbers of CD3+ T cells, CD45RA+ naive and
CD45RC+ memory T cells in the lamina propria
and Peyer’s patches of jejunum and ileum of
weaned pigs. It is likely that increased num-
bers of CD3+, CD45RA+ and CD45RC+ T cells in
jejunal  and  ileal  lamina  propria  and  ileal
Peyer's patches are reflecting the initiation of
specific  responses  induced  by  vaccination
(with or without levamisole applied as an adju-
vant), which may result in the induction of the
protective immunity at mucosal surfaces of the
gut. Our quantitative data on intestinal B cell
response recorded by changes in the number
of CD21+ cells following nonajuvanted and lev-
amisole-adjuvanted vaccination revealed that
later combination had less effect on prolifera-
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Table 5. Morphometric data of lymphoid and myeloid cell subsets in ileum of pigs
immunized with either vaccine candidate F4ac+non-ETEC strain or with combination of
levamisole and F4ac+non-ETEC. The results are expressed as the mean values and stan-
dard deviations of  the number of cells per µm2 of tissue section field; in every sample
the cells were counted in 12 randomly chosen fields with the average area of 672387.5
µm2.
Treatment Mean±SD(x10
–5) number of lymphoid and myeloid 
of pigsa cells residing ileal mucosa 
CD3 CD45RA CD45RC CD21 SWC3
Noneb 3.14±0.47 12.2±4.17 2.98±0.7 4.93±1.67 1.42±0.86
F4ac+non 21.6±9.47* 113.0±21.8*** 15.2±9.97 84.2±16.8*** 9.26±1.25***
ETEC
Levamisole 18.6±3.39*** 155.0±65.3* 19.5±6.85* 88.4±23.5** 10.6±3.13**
+F4ac+
non-ETEC
aGroups comprised five 4-weeks-old pigs each. bControl pigs received saline as a placebo. Significantly different at *P<0.05, **<0,01
or ***<0.001 than in the control nontreated pigs. 
Table 4. Morphometric data of lymphoid and myeloid cell subsets in jejunum of pigs
immunized with either vaccine candidate F4ac+non-ETEC strain or with combination of
levamisole and F4ac+non-ETEC. The results are expressed as the mean values and stan-
dard deviations of  the number of cells per µm2 of tissue section field; in every sample the
cells were counted in 12 randomly chosen fields with the average area of 672387.5 µm2.
Treatment Mean±SD(x10
–5) number of lymphoid and myeloid 
of pigsa cells residing jejunal mucosa 
CD3 CD45RA CD45RC CD21 SWC3
Noneb 1.54±0.61 6.84±2.06 2.25±0.50 1.7±1.19 1.39±0.09
F4ac
+ 20.3±3.84** 60.4±7.44** 13.8±4.32* 46.0±4.42** 7.96±2.15*
non ETEC
Levamisole+ 15.9±5.44* 79.1±13.8** 18.5±4.55* 27.5±8.29* 7.62±1.71*
F4ac
+
non-ETEC
aGroups comprised five 4-weeks-old pigs each. bControl pigs received saline as a placebo. Significantly different at: *P<0,01 or
**<0.001 than in the control nontreated pigs.
ntly different at: *P<0,01 or **<0.001 than in the control nontreated pigs.[European Journal of Histochemistry 2010; 54:e4] [page 23]
tion  of  jejunal  B  cells,  indicating  that  lev-
amisole did not affect these cell subset as it did
with T cell subsets tested. This is in agreement
with earlier findings that levamisole has abili-
ty to stimulate T cells and macrophages, but
not B cells26 or that its effect on these cells is
questionable.27 Indeed, the immunostimulato-
ry effect of levamisole (when given in combi-
nation with the vaccine) was more pronounced
for  T  cells,  particularly  CD45RA+ naïve  and
CD45RC+ memory  T  cells,  than  for  CD21+B
cells.  Increased  numbers  of  SWC3+ myeloid
cells (macrophages/granulocytes) in jejunum
and ileum, and their distribution in the areas
below  epithelium  of  villi  and  inside  Peyer’s
patches,  indicated  their  role  in  presenting
antigens of vaccine candidate non-ETEC strain
to T cells, and thus, commencing induction of
specific immune response within small intes-
tinal mucosa. Since we have found increased
number of SWC3+ cells in the small intestinal
mucosa  of  both  principal  groups  of  pigs,  it
seems  that  levamisole  given  as  an  adjuvant
was not prerequisite for recruitment of jejunal
and  ileal  macrophages/granulocytes  as  sug-
gested by others.26
The succes of vaccination against PWC in
our model system depends largely upon quan-
titative parameters of intestinal cellular immu-
nity, but it also relies on data regarding mortal-
ity, incidence/severity of diarrhea, growth per-
formance and shedding of virulent strains of E.
coli. Although all 5 pigs developed diarrhea in
both principal groups of pigs and only 3 of 5 in
control group of pigs, it is very likely that they
were infected prior to start of the experiment.
Namely, they became diarrheic at day 1 and
died  at  day  9  (in  nonajuvanted-vaccinated
group) and at day 3 (in levamisole adjuvanted-
vaccinated group) of the experiment. 
According to diarrhea scoring, it is obvious
that pigs from group treated with vaccine can-
didate strain had moderate to severe diarrhea
of 4-8 days of duration. Control pigs and those
that  received  levamisole  adjuvanted  vaccine
had mild to moderate diarrhea of either 3-5 or
2-6 days of duration, respectively. 
However, control pigs had highest CFU num-
ber (4.0x107) as compared to both  principal
groups  (5.5-6.0x106).  As  we  have  observed
diarrhea  in  each  group  of  pigs  (Table  2;
although of different intensity/duration, and in
different no. of pigs per group) we have select-
ed  for  euthanasia  and  sampling  3  pigs  per
group based on the following criteria: i) pres-
ence or absence of diarrhea, ii) intensity of
diarrhea, and iii) duration of diarrhea. In order
to obtain as much as possible uniform samples
of jejunum and ileum for immunohistology, we
have euthanatized pigs that were closely uni-
form regarding diarrhea status. 
Moreover,  analyzing  quantitative  data
obtained by histomorphometry (Tables 4 and
5), it is obvious that the presence of diarrhea
in sampled pigs from all three groups did not
influence neither the expression of CD/SWC
antigens on lymphoid and myeloid cell subsets
tested nor their quantitative and distribution
patterns. Thus, we assume that such sampling
may objectively reflect the effects of immuniz-
ing agents applied on development of the pro-
tective immunity as established by highly ele-
vated proliferation of immune cell subsets test-
ed  in  both  groups  of  immunized  pigs.  Our
assumption is based on the fact that both prin-
cipal groups of pigs had significantly increased
numbers of all cell subsets tested at day 13 fol-
lowing either specific or non-specific/specific
immunization  and  challenge  infection.  Also,
based on DIA analyses we may undoubtedly dif-
ferentiate the intestinal immune response of
pigs induced by an experimental mucosal (aju-
vanted  or  nonajuvanted)  vaccine  from  that
observed in the respective sites of the GALT of
non-vaccinated pigs. 
Finally,  our  results  confirmed  that  F4ac+
non-ETEC  strain  stimulated  proliferation  of
several immune cell subsets in the jejunal and
ileal mucosa of weaned pigs, and thus it should
be  further  studied  as  a  vaccine  candidate
strain for the prevention and control of PWC.
However, present study has failed to confirm
levamisole, when given with F4ac+ non-ETEC
strain,  as  an  efficient  adjuvant  for  mucosal
vaccines.  Although  our  recent  approach  has
been at least partially successful, such as those
in the past, developing of a safe and effective
vaccine against PWC that will provide solid and
sustained immune responses remains a formi-
dable challenge.
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